Dexamethasone suppression for 18F-FDG PET/CT to localize ACTH-secreting pituitary tumors

Cancer Imaging

Table 4 Qualitative analysis by diagnostic modalities for CD

Sub No.	Sex, Age		DEX suppression ¹⁸F-FDG PET/CT	MRI	Size(mm)	BIPSS
1	F,56	+	+	+	28.00
2	F,36	+(right/midline)	+	+	18.00
3	F,34	+	+	+	11.20	+
4	F,47	+	+	+	11.00
5	F,41	+	+	+	11.00
6	F,44	+	+	+	20.00
7	F,42	+	+	+	9.70
8	F,52	+(right/midline)	+	+	9.00	-
9	F,53	+	+	+	8.00	+
10	F,31	-	-	+	8.00
11	F,37	+	+	+	7.70	+
12	F,46	+	+	+	6.50	+
13	F,55	+	+	+	6.00	+
14	F,33	-	-	+	5.50	-
15	F,38	+	+	+	5.00
16	F,20	+(right/midline)	+	+	2.00	+
17	M,26	+	+	-	-	+
18	F,13	+	+	+	6.00
19	F,14	-	-	+	5.50	+
20	F,51	+	+/-	+	4.00	+
21	F,17	-	-	+	2.00	+
22	M,19	-	-	-	-	+

CD, Cushing’s disease; Sub No., Subject number; ¹⁸F-FDG-PET/CT; ¹⁸ F-fluorodeoxyglucose positron emission tomography/computed tomography; DEX, dexamethasone; MRI, magnetic resonance imaging; BIPSS, bilateral inferior petrosal sinus sampling;

ISSN: 1470-7330